DatasetOpen accessZenodo
Insurance Coverage for Ketamine Therapies: A Comprehensive Analysis of Coverage Patterns Among Major U.S. Health Insurers
Abstract
This dataset catalogs coverage positions and gatekeeping requirements for four ketamine therapy modalities (Spravato, IV, IM, oral/sublingual) across 18 major U.S. commercial insurers, including policy URLs and last-updated dates.
Topics & conditions
Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.
Keywords
Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.
Related research
ArticleMDMA
Chemsex drugs: More than ghb, mephedrone and methamphetamine?
ArticleKetamine
Midazolam-Ketamine (MK) Versus Propofol-Ketamine (PK) for Pediatric Burn Patients Undergoing Dressing Changes: A Non-Randomized Cross-Over Clinical Trial.
ArticleKetamine